905
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Role of rotavirus vaccination on G9P[8] rotavirus strain during a seasonal outbreak in Japan

, , , , , , , , , , , , , & show all
Pages 3613-3618 | Received 06 Mar 2021, Accepted 27 Apr 2021, Published online: 25 May 2021

References

  • Abou-Nader AJ, Sauer MA, Steele AD, Tate JE, Atherly D, Parashar UD, Santosham M, Nelson EAS. Global rotavirus vaccine introductions and coverage: 2006–2016. Hum Vaccin Immunother. 2018;14(9):2281–96. doi:10.1080/21645515.2018.1470725. PMID: 29787334.
  • Hoque SA, Kobayashi M, Takanashi S, Anwar KS, Watanabe T, Khamrin P, Okitsu S, Hayakawa S, Ushijima H. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan. Vaccine. 2018;36(1):43–49. doi:10.1016/j.vaccine.2017.11.056. PMID: 29183732.
  • Haidong W, Zulfiqar AB, Matthew MC, Megan C, Lalit D, Khassoum D, Elisabeth BF, Maya F, Nancy F, Peter WG, et al. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1725–74. doi:10.1016/S0140-6736(16)31575-6. PMID: 27733285.
  • Carvalho MF, Gill D. Rotavirus vaccine efficacy: current status and areas for improvement. Hum Vaccin Immunother. 2019;15(6):1237–50. doi:10.1080/21645515.2018.1520583. PMID: 30215578.
  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41. doi:10.1016/S1473-3099(11)70253-5. PMID: 22030330.
  • Fujii Y, Noguchi A, Miura S, Ishii H, Nakagomi T, Nakagomi O, Takahashi T. Effectiveness of rotavirus vaccines against hospitalisations in Japan. BMC Pediatr. 2017;17(1):156. doi:10.1186/s12887-017-0916-7. PMID: 28693503.
  • NIID. Rotavirus, from September 2004 to August 2019, Japan. IASR; 2020 Apr 9 [accessed 2021 Mar 4]. https://www.niid.go.jp/niid/en/a-h7n9-en/865-iasr/9543-478te.html.
  • Araki K, Hara M, Sakanishi Y, Shimanoe C, Nishida Y, Matsuo M, Tanaka K. Estimating rotavirus vaccine effectiveness in Japan using a screening method. Hum Vaccin Immunother. 2016;12(5):1244–49. doi:10.1080/21645515.2015.1121337. PMID: 26680277.
  • Ministry of Health LaWJ. Committee for immunization and vaccines. Evaluations and analyses on rotavirus vaccines (Report 1–3). 2015.
  • Hoque SA, Khandoker N, Thongprachum A, Khamrin P, Takanashi S, Okitsu S, Nishimura S, Kikuta H, Yamamoto A, Sugita K, et al. Distribution of rotavirus genotypes in Japan from 2015 to 2018: diversity in genotypes before and after introduction of rotavirus vaccines. Vaccine. 2020;38(23):3980–86. doi:10.1016/j.vaccine.2020.03.061. PMID: 32307276.
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664. PMID: 16394299.
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434. PMID: 16394298.
  • Heylen E, Zeller M, Ciarlet M, Lawrence J, Steele D, Van Ranst M, Matthijnssens J. Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa. Sci Rep. 2015;5(1):14658. doi:10.1038/srep14658. PMID: 26440913.
  • Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12(1):213. doi:10.1186/1471-2334-12-213. PMID: 22974466.
  • Mokomane M, Esona MD, Bowen MD, Tate JE, Steenhoff AP, Lechiile K, Gaseitsiwe S, Seheri LM, Magagula NB, Weldegebriel G, et al. Diversity of rotavirus strains circulating in Botswana before and after introduction of the monovalent rotavirus vaccine. Vaccine. 2019;37(43):6324–28. doi:10.1016/j.vaccine.2019.09.022.
  • Markkula J, Hemming-Harlo M, Salminen MT, Savolainen-Kopra C, Pirhonen J, Al-hello H, Vesikari T. Rotavirus epidemiology 5–6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly. Infect Dis (Lond). 2017;49(5):388–95. doi:10.1080/23744235.2016.1275773.
  • Kirkwood C, Bogdanovic-Sakran N, Barnes G, Bishop R. Rotavirus serotype G9P[8] and acute gastroenteritis outbreak in children, Northern Australia. Emerg Infect Dis. 2004;10(9):1593–600. doi:10.3201/eid1009.040040.
  • Snelling TL, Schultz R, Graham J, Roseby R, Barnes G, Andrews R, Carapetis J. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin Infect Dis. 2009;49(3):428–31. doi:10.1086/600395.
  • Justino MCA, Araújo EC, Van Doorn L-J, Oliveira CS, Gabbay YB, Mascarenhas JDP, Miranda YS, Guerra SDFS, Silva VBD, Linhares AC, et al. Oral live attenuated human rotavirus vaccine (RotarixTM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children. Mem Inst Oswaldo Cruz. 2012;107(7):846–53. doi:10.1590/S0074-02762012000700002.
  • Fukuda S, Tacharoenmuang R, Guntapong R, Upachai S, Singchai P, Ide T, Hatazawa R, Sutthiwarakom K, Kongjorn S, Onvimala N, et al. Full genome characterization of novel DS-1-like G9P[8] rotavirus strains that have emerged in Thailand. PLoS One. 2020;15(4):e0231099. doi:10.1371/journal.pone.0231099.
  • Fujii Y, Oda M, Somura Y, Shinkai T. Molecular characteristics of novel mono-reassortant G9P[8] rotavirus A strains possessing the NSP4 gene of the E2 genotype detected in Tokyo, Japan. Jpn J Infect Dis. 2019;73(1):26–35. doi:10.7883/yoken.JJID.2019.211.
  • Tian Y, Chughtai AA, Gao Z, Yan H, Chen Y, Liu B, Huo D, Jia L, Wang Q, MacIntyre CR, et al. Prevalence and genotypes of group A rotavirus among outpatient children under five years old with diarrhea in Beijing, China, 2011–2016. BMC Infect Dis. 2018;18(1):497. doi:10.1371/journal.pone.0231099.
  • Kaplon J, Grangier N, Pillet S, Minoui-Tran A, Vabret A, Wilhelm N, Prieur N, Lazrek M, Alain S, Mekki Y, et al. Predominance of G9P[8] rotavirus strains throughout France, 2014–2017. Clin Microbiol Infect. 2018;24(6):660 e661–660 e664. doi:10.1016/j.cmi.2017.10.009.
  • Lewis K. Vesikari clinical severity scoring system manual. PATH, A Catalyst for global health; 2011. p. 9–11.
  • Thongprachum A, Khamrin P, Pham NTK, Takanashi S, Okitsu S, Shimizu H, Maneekarn N, Hayakawa S, Ushijima H. Multiplex RT-PCR for rapid detection of viruses commonly causing diarrhea in pediatric patients. J Med Virol. 2017;89(5):818–24. doi:10.1002/jmv.24711.
  • Hoque SA, Islam MT, Kobayashi M, Takanashi S, Anwar KS, Watanabe T, Khamrin P, Okitsu S, Hayakawa S, Ushijima H, et al. Our response to the letter to the editor. Vaccine. 2018;36(34):5110–11. doi:10.1016/j.vaccine.2018.05.004.
  • Chan YH. Biostatistics 202: logistic regression analysis. Singapore Med J. 2004;45:149–53.
  • Schlesselman JJ. Case-control studies: design, conduct, analysis. NewYork: Oxford University Press; 1982.
  • Hoque SA, Thongprachum A, Takanashi S, Mostafa SM, Saito H, Anwar KS, Nomura A, Hoque SA, Begum R, Sultana UN, et al. Alarming situation of spreading enteric viruses through sewage water in Dhaka City: molecular epidemiological evidences. Food Environ Virol. 2019;11(1):65–75. doi:10.1007/s12560-018-09363-z.
  • Takanashi S, Thongprachum A, Okitsu S, Nishimura S, Kobayashi M, Kikuta H, Yamamoto A, Sugita K, Baba T, Hayakawa S, et al. Molecular epidemiological traits of group a rotaviruses in Japanese children during transitional period of rotavirus vaccine implementation, 2011–2014. Clin Lab. 2017;63:961–70. doi:10.7754/Clin.Lab.2017.161216.
  • WHO. Immunization, vaccines and biologicals; 2019 [accessed 2021 Mar 4]. https://www.who.int/immunization/diseases/rotavirus/en/ .
  • Dey SK, Ushijima H, Phathammavong O, Chanit W, Okitsu S, Mizuguchi M, Ota Y. Seasonal trend and serotype distribution of rotavirus infection in Japan, 1981–2008. Pediatr Infect Dis J. 2010;29(2):166–67. doi:10.1097/INF.0b013e3181b79460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.